Dermatomyositis: An association of gingival telangiectases and anti Jo-1 antibody in the adult

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 16, Issue 2, 2007, Pages 67-72

  Dourmishev, Lyubomir A ^a   Dourmishev, Assen L ^a   Schwartz, Robert A ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Antisynthetase syndrome; Dermatomyositis; Gingival telangiectases

Indexed keywords

ANTIBODY; AZATHIOPRINE; JO 1 ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CHEMICAL ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DERMATOMYOSITIS; ELECTROMYOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVA DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LOW DRUG DOSE; MUSCLE BIOPSY; MUSCLE STRENGTH; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; SKIN BIOPSY; TELANGIECTASIA;

ANTIBODIES, ANTINUCLEAR; DERMATOMYOSITIS; FEMALE; GINGIVAL DISEASES; HUMANS; MIDDLE AGED; SKIN; TELANGIECTASIS;

EID: 34347396201     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971-82.
2. Dourmishev LA, Dourmishev AL, Schwartz RA. Dermatomyositis: cutaneous manifestations of its variants. Int J Dermatol. 2002;41:625-30.
3. Ghali FE, Stein LD, Fine JD, Burkes EJ, McCauliffe DP. Gingival telangiectases. An underappreciated physical sign of juvenile dermatomyositis. Arch Dermatol. 1999;135:1370-4.
4. Keil H. The manifestations in the skin and mucous membranes in dermatomyositis, with special reference to the differential diagnosis from systemic lupus erythematosus. Ann Intern Med. 1942;16:828-71.
5. Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum. 1980;23:881-8.
6. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature. 1983;304:177-9.
7. Tanimoto K, Nakano K, Kano S, Mori S, Ueki H, Nishitani H et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol. 1995;22:668-74.
8. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344-7;403-7.
9. Reining E. Versammlungen Casus 3 und 4. Dermatol Wochenschr. 1939;109:1198-9.
10. Gottron HA, Schönfeld W, editors. Dermatologie und Venerologie. Stuttgart: Thieme; 1958. Vol. 2, Part 1, p. 548.
11. Kunte Ch, Plewig G. Das "Keining-Zeichen" bei Dermatomyositis. Hautarzt. 1998;49:596-7.
12. O'Leary P. Dermatomyositis. Arch Dermatol. 1953;68:101-2.
13. Christianson HB, Brunsting LA, Perry HO. Dermatomyositis: unusual features, complications and treatment. Arch Dermatol. 1954;74:581-9.
14. Wong KO. Dermatomyositis: A clinical investigation of 23 cases in Hong Kong. Br J Dermatol. 1969; 81:544-7.
15. Dupre A, Floutard X, Christol B et al. Dermatomyosite avec spinulosisme (dermatomyosite type Wong). Etude histologique: essai d'interpretation pathogenique. Ann Dermatol Syphiligr (Paris). 1976;103:141-9.
16. Requena L, Grilli R, Soriano L, Escalonilla P, Farina C, Martin L. Dermatomyositis with a pityriasis rubra pilaris-like eruption: a little-known distinctive cutaneous manifestation of dermatomyositis. Br J Dermatol. 1997;136:768-71.
17. Lupton JR, Figueroa P, Berberian BJ, Sulica VI. An unusual presentation of dermatomyositis: The type Wong variant revised. J Am Acad Dermatol. 2000;43:908-12.
18. Oppenheim H. Über die Polymyositis. Berl Klin Wochenschr. 1903;40:381-5.
19. Schuerman H. Zür Klinik und Pathogenese der Dermatomyositis [Polymyositis]. Arch Derm Syphilol. 1939;178:414-68.
20. Sanger RG, Kirby JW. The oral and facial manifestations of dermatomyositis with calcinosis. Oral Surg Oral Med Oral Pathol. 1973;35:476-88.
21. Callen JP. Oral manifestations of collagen vascular disease. Semin Cutan Med Surg. 1997;16:323-7.
22. Samitz MH. Cuticular changes in dermatomyositis: A clinical sign. Arch Dermatol. 1974;110:866.
23. Franks AG. Important cutaneous markers of dermatomyositis. J Musculoskel Med. 1988;5:39-63.
24. Norins AL. Juvenile dermatomyositis. Med Clin of North Am. 1989;73:1193-209.
25. Banker BQ, Victor M. Dermatomyositis (systemic angiopathy) of childhood. Medicine (Baltimore). 1966;45:261-89.
26. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol. 1990;48:26-30.
27. Crowson AN, Margo CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol. 1996;27:15-9.
28. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med. 1986;314:329-4.
29. Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol. 2000;12:475-81.
30. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogenous patient group. Medicine (Baltimore). 1991;70:360-74.
31. Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol. 1993;100:S116-23.
32. Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990;282:1019-38.
33. Ray DW, Bridger J, Hawnaur J, Waldek S, Bernstein RM, Dornan TL. Transverse myelitis as the presentation of Jo-1 antibody syndrome (myositis and fibrosing alveolitis) in long-standing ulcerative colitis. Br J Rheumatol. 1993;32:1105-8.
34. Mitra D, Lovell CL, Macleod TI, Tan RS, Maddison PJ. Clinical and histological features of "mechanic's hands" in a patient with antibodies to Jo-1 a case report. Clin Exp Dermatol. 1994;19:146-8.
35. Dourmishev L, Wollina U, Hipler UC, Peytcheva V. Myositis-specific and myositis-associated autoantibodies in dermatomyositis and polymyositis. Clin Appl Immunol. 2006;5:533-7.
36. Schmidt WA, Wetzel W, Friedlander R, Lange R, Sorensen HE, Lichey HJ et al. Clinical and serological aspects of patients with anti-Jo-1 antibodies - an evolving spectrum of disease manifestations. Clin Rheumatol. 2000;19:371-7.
37. Callen JP. Dermatomyositis. Lancet. 2000;355:53-7.
38. Marton K, Hermann P, Danko K, Fejerdy P, Madlena M, Nagy G. Evaluation of oral manifestations and masticatory force in patients with polymyositis and dermatomyositis. J Oral Pathol Med. 2005;34:164-9.
39. Healy CM, Tobin AM, Kirby B, Flint SR. Oral lesions as an initial manifestation of dermatomyositis with occult malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:184-7.